Skip to content

A Shared Decision-making Training for Inpatients With Schizophrenia

A Shared Decision-making Training for Inpatients With Schizophrenia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02349880
Enrollment
264
Registered
2015-01-29
Start date
2011-10-31
Completion date
2015-03-31
Last updated
2018-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizo-affective Disorder, Schizophrenia

Brief summary

Shared decision-making is being promoted as a promising approach for engaging patients with schizophrenia in medical decisions and improving satisfaction and adherence. To implement shared decision-making, both physicians and patients should commit to it and engage in a mutual decision process. Most research, however, has addressed interventions that either focus on the doctors' side (e.g. communication skills) or on informing patients about treatment options (e.g. decision aids). These approaches have been shown to be feasible in clinical practice but had no strong effects on treatment patterns or adherence, possibly because they were insufficient to motivate and enable patients to engage actively in decision-making. Moreover, these interventions still rely on the doctor's willingness to share decisions, which has been shown to vary considerably. To overcome these limitations and since many patients do not feel competent to participate in decision-making we developed an intervention that focuses on patients' communicative competencies. this intervention, a five session group-training, will be implemented for inpatients suffering from schizophrenia.

Interventions

BEHAVIORALshared decision making training

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age 18-65 * icd diagnosis F2 * sufficient German language skills

Exclusion criteria

* debility

Design outcomes

Primary

MeasureTime frame
adherence to antipsychotic medication12 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026